<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fifteen patients with myelodysplastic/<z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> were treated with high-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>While severe toxicity was produced in every patient, only two of the 15 patients entered complete remission and two achieved partial remission status </plain></SENT>
<SENT sid="2" pm="."><plain>The therapeutic responses were confined to patients who had severe <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> of apparently recent <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
</text></document>